For years, connecting an inhaler meant clipping a sensor onto one. RS01X moves sensing into the device itself. It brings Respiro technology to the RS01, Plastiape's widely used capsule inhaler, so connectivity is built in from the start.
The 2020 agreement brought complementary roles together: Amiko's digital services and Respiro platform alongside the device development, manufacturing and supply behind RS01. The aim was a connected inhaler that preserves a proven device.
RS01X records inhaler use and technique, stores the data on the device and transfers it wirelessly to the Respiro app. The companion app brings reminders and inhalation history together, with options for patients to share that history with their care team.
"The introduction of the RS01X is a significant milestone for Berry Healthcare globally, as well as for innovation in respiratory devices."
Vincent Clauzel, Managing Director, Care Unit, Berry Global (now Amcor)
"The integration of sensing and connectivity into our RS01X inhaler will help to improve patients' lives, as we bring together the power of digital technology and data science with the premier platform for inhalation technology."
Muriel Combeau, Sales & Marketing Director, Berry Healthcare (now Amcor)
"We've always believed respiratory care belongs in the digital age. With RS01X, the inhaler millions already use becomes connected from the first dose, and with the right partner behind it, that reaches patients at a scale that genuinely changes outcomes."
Martijn Grinovero, Chief Commercial Officer, Amiko
Originally published 7 December 2020.